923 related articles for article (PubMed ID: 19386283)
1. Sildenafil therapy in secondary pulmonary hypertension: Is there benefit in prolonged use?
Chapman TH; Wilde M; Sheth A; Madden BP
Vascul Pharmacol; 2009; 51(2-3):90-5. PubMed ID: 19386283
[TBL] [Abstract][Full Text] [Related]
2. Does Sildenafil produce a sustained benefit in patients with pulmonary hypertension associated with parenchymal lung and cardiac disease?
Madden BP; Sheth A; Wilde M; Ong YE
Vascul Pharmacol; 2007; 47(2-3):184-8. PubMed ID: 17627899
[TBL] [Abstract][Full Text] [Related]
3. A potential role for sildenafil in the management of pulmonary hypertension in patients with parenchymal lung disease.
Madden BP; Allenby M; Loke TK; Sheth A
Vascul Pharmacol; 2006 May; 44(5):372-6. PubMed ID: 16574495
[TBL] [Abstract][Full Text] [Related]
4. Sildenafil therapy for pulmonary arterial hypertension associated with atrial septal defects.
Lim ZS; Salmon AP; Vettukattil JJ; Veldtman GR
Int J Cardiol; 2007 May; 118(2):178-82. PubMed ID: 17027100
[TBL] [Abstract][Full Text] [Related]
5. Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension.
Lewis GD; Shah R; Shahzad K; Camuso JM; Pappagianopoulos PP; Hung J; Tawakol A; Gerszten RE; Systrom DM; Bloch KD; Semigran MJ
Circulation; 2007 Oct; 116(14):1555-62. PubMed ID: 17785618
[TBL] [Abstract][Full Text] [Related]
6. One year efficacy and safety of oral sildenafil treatment in severe pulmonary hypertension.
Samarzija M; Zuljević E; Jakopović M; Sever B; Knezević A; Dumija Z; Vidjak V; Samija M
Coll Antropol; 2009 Sep; 33(3):799-803. PubMed ID: 19860106
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy of oral sildenafil as rescue therapy in patients with severe pulmonary arterial hypertension chronically treated with prostacyclin. Long-term results].
Jiménez López-Guarch C; Escribano Subias P; Tello de Meneses R; Delgado Jiménez JF; Sadia Pérez D; Velázquez Martín MT; Gómez Sánchez MA; Sáenz de la Calzada C
Rev Esp Cardiol; 2004 Oct; 57(10):946-51. PubMed ID: 15469792
[TBL] [Abstract][Full Text] [Related]
8. Sildenafil for pulmonary hypertension secondary to congenital heart diseases.
Gupta A; Kerkar P
Indian Heart J; 2007; 59(4):342-5. PubMed ID: 19126940
[TBL] [Abstract][Full Text] [Related]
9. Role of oral sildenafil in severe pulmonary arterial hypertension: clinical efficacy and dose response relationship.
Garg N; Sharma MK; Sinha N
Int J Cardiol; 2007 Sep; 120(3):306-13. PubMed ID: 17174417
[TBL] [Abstract][Full Text] [Related]
10. Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension.
Michelakis ED; Tymchak W; Noga M; Webster L; Wu XC; Lien D; Wang SH; Modry D; Archer SL
Circulation; 2003 Oct; 108(17):2066-9. PubMed ID: 14568893
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of transition from subcutaneous treprostinil to oral sildenafil in patients with pulmonary arterial hypertension.
Keogh AM; Jabbour A; Weintraub R; Brown K; Hayward CS; Macdonald PS
J Heart Lung Transplant; 2007 Nov; 26(11):1079-83. PubMed ID: 18022071
[TBL] [Abstract][Full Text] [Related]
12. The efficacy and tolerability of sildenafil in patients with moderate-to-severe pulmonary hypertension.
Bharani A; Mathew V; Sahu A; Lunia B
Indian Heart J; 2003; 55(1):55-9. PubMed ID: 12760589
[TBL] [Abstract][Full Text] [Related]
13. Chronic oral sildenafil therapy in severe pulmonary artery hypertension.
Kothari SS; Duggal B
Indian Heart J; 2002; 54(4):404-9. PubMed ID: 12462669
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of sildenafil as a rescue therapy for patients with severe pulmonary arterial hypertension and given long-term treatment with prostanoids: 2-year experience.
Ruiz MJ; Escribano P; Delgado JF; Jiménez C; Tello R; Gómez MA; de la Calzada CS
J Heart Lung Transplant; 2006 Nov; 25(11):1353-7. PubMed ID: 17097500
[TBL] [Abstract][Full Text] [Related]
15. Clinical and haemodynamic effects of sildenafil in pulmonary hypertension: acute and mid-term effects.
Mikhail GW; Prasad SK; Li W; Rogers P; Chester AH; Bayne S; Stephens D; Khan M; Gibbs JS; Evans TW; Mitchell A; Yacoub MH; Gatzoulis MA
Eur Heart J; 2004 Mar; 25(5):431-6. PubMed ID: 15033256
[TBL] [Abstract][Full Text] [Related]
16. Six-minute walk distance as parameter of functional outcome after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension.
Reesink HJ; van der Plas MN; Verhey NE; van Steenwijk RP; Kloek JJ; Bresser P
J Thorac Cardiovasc Surg; 2007 Feb; 133(2):510-6. PubMed ID: 17258590
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary hypertension in end-stage pulmonary sarcoidosis: therapeutic effect of sildenafil?
Milman N; Burton CM; Iversen M; Videbaek R; Jensen CV; Carlsen J
J Heart Lung Transplant; 2008 Mar; 27(3):329-34. PubMed ID: 18342757
[TBL] [Abstract][Full Text] [Related]
18. Beneficial effect of oral sildenafil therapy on childhood pulmonary arterial hypertension: twelve-month clinical trial of a single-drug, open-label, pilot study.
Humpl T; Reyes JT; Holtby H; Stephens D; Adatia I
Circulation; 2005 Jun; 111(24):3274-80. PubMed ID: 15956137
[TBL] [Abstract][Full Text] [Related]
19. The efficacy and safety of sildenafil in Chinese patients with pulmonary arterial hypertension.
Xu XQ; Jing ZC; Zhang JH; Wu Y; Wang Y; Jiang X; Wang ZX; Sun YG; Pu JL; Yang YJ
Hypertens Res; 2009 Oct; 32(10):911-5. PubMed ID: 19644505
[TBL] [Abstract][Full Text] [Related]
20. Sildenafil citrate therapy for pulmonary arterial hypertension.
Galiè N; Ghofrani HA; Torbicki A; Barst RJ; Rubin LJ; Badesch D; Fleming T; Parpia T; Burgess G; Branzi A; Grimminger F; Kurzyna M; Simonneau G;
N Engl J Med; 2005 Nov; 353(20):2148-57. PubMed ID: 16291984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]